Detail
| LncRNA Name | MEG3 |
| Synonyms | MEG3, FP504, GTL2, LINC00023, NCRNA00023, PRO0518, PRO2160, onco-lncRNA-83, prebp1 |
| Region | GRCh38_14:100779410-100861031 Sequence |
| Ensembl | ENSG00000214548 |
| RefSeq | NR_002766 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✔ |
| Cancer Name | pituitary adenoma |
| ICD-0-3 | C75.1 M8272/0 |
| Methods | qPCR etc. |
| Sample | pituitary tumor tissues |
| Expression Pattern | down-regulated |
| Function Description | In summary, MEG3 and GADD45γ expression was significantly lost in most clinically non-functioning adenomas (78 and 92%, respetcively). Other assessed pituitary tumor phenotypes expressed both genes at significantly different levels, and, in some cases, with overexpression. |
| Pubmed ID | 21850407 |
| Year | 2012 |
| Title | Expression of cell growth negative regulators MEG3 and GADD45γ is lost in most sporadic human pituitary adenomas. |
| External Links |
| Links for MEG3 | GenBank HGNC lncrnadb Noncode |
| Links for pituitary adenoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.